Family Medicine · Fort Myers, FL
NPI
1457640666
Since 2011
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
13813 Metro Pkwy
Fort Myers, FL, 33912
Phone (239) 936-1343
Groups this clinician bills Medicare through
Medicare paid, 2024
$112K
2,935 services
Medicare patients, 2024
232
Average age 75
Drug cost, 2024
$948K
7,446 prescriptions
Company payments, 2025
$1,077
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Luis Cardentey was code 99214 (office e&m - established), 536 times for 216 patients. In total Luis Cardentey billed 2,935 services in 49 codes, and Medicare paid $112K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 536 | 216 | $87.97 | $47K |
| 36415 Venipuncture Blood Collection | Office | 258 | 142 | $8.65 | $2,232 |
| 80053 Clinical Chemistry | Office | 243 | 141 | $10.35 | $2,515 |
| 80061 Clinical Chemistry | Office | 233 | 138 | $13.12 | $3,057 |
| 85025 Blood Count | Office | 222 | 135 | $7.61 | $1,689 |
| 84443 Clinical Chemistry | Office | 200 | 120 | $16.46 | $3,292 |
| 84439 Clinical Chemistry | Office | 195 | 118 | $8.84 | $1,724 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 131 | 131 | $130.38 | $17K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 127 | 127 | $18.70 | $2,375 |
| 96372 Injection Administration | Office | 115 | 13 | $9.50 | $1,092 |
| 99497 Care Management/Coordination | Office | 105 | 103 | $78.00 | $8,189 |
| 83036 Blood Count | Office | 96 | 49 | $9.52 | $914 |
| 99215 Office E&M - Established | Office | 32 | 28 | $122.56 | $3,922 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | Office | 31 | 31 | $18.92 | $587 |
| 84153 Clinical Chemistry | Office | 25 | 19 | $18.02 | $451 |
By year: 2022 $122K for 2,299 services; 2023 $120K for 2,217 services; 2024 $112K for 2,935 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 258 | 142 | $8.65 | $2,232 |
| 80053 Clinical Chemistry | 243 | 141 | $10.35 | $2,515 |
| 80061 Clinical Chemistry | 233 | 138 | $13.12 | $3,057 |
| 85025 Blood Count | 222 | 135 | $7.61 | $1,689 |
| 84443 Clinical Chemistry | 200 | 120 | $16.46 | $3,292 |
| 84439 Clinical Chemistry | 195 | 118 | $8.84 | $1,724 |
| 83036 Blood Count | 96 | 49 | $9.52 | $914 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | 31 | 31 | $18.92 | $587 |
| 84153 Clinical Chemistry | 25 | 19 | $18.02 | $451 |
| 81001 Clinical Chemistry | 13 | 11 | $3.11 | $40.43 |
Medicare prescription drug claims, 2024
In 2024, the drug Luis Cardentey prescribed most often to Medicare patients was Levothyroxine Sodium, with 358 prescriptions and refills. In total Luis Cardentey wrote 7,446 Medicare prescriptions that cost $948K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 358 | 1,047 | 109 | $3,186 |
| Metformin Hcl Generic | 299 | 826 | 87 | $1,659 |
| Atorvastatin Calcium Generic | 276 | 812 | 89 | $1,646 |
| Amlodipine Besylate Generic | 249 | 708 | 85 | $1,207 |
| Rosuvastatin Calcium Generic | 229 | 653 | 86 | $2,281 |
| Alprazolam Generic | 217 | 269 | 42 | $1,161 |
| Atenolol-Chlorthalidone Atenolol/Chlorthalidone | 204 | 562 | 64 | $4,095 |
| Lisinopril Generic | 190 | 561 | 57 | $1,030 |
| Metoprolol Succinate Generic | 183 | 512 | 58 | $2,089 |
| Omeprazole Generic | 146 | 398 | 44 | $2,139 |
| Losartan Potassium Generic | 130 | 377 | 43 | $620 |
| Prednisone Generic | 126 | 158 | 76 | $499 |
| Tamsulosin Hcl Generic | 125 | 325 | 42 | $1,076 |
| Pantoprazole Sodium Generic | 124 | 362 | 41 | $1,258 |
| Gabapentin Generic | 107 | 245 | 37 | $1,900 |
Brand drugs: 1,092 claims; generic drugs: 6,298 claims; opioid claims: 117.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Luis Cardentey $1,077 ($1,077 in general payments such as food, travel and fees) from 15 companies. The largest payer was Optinose US, Inc. with $257.
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 2 | $257 |
| Amgen Inc. AMGN | 5 | $191 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $186 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $99.84 |
| Abbvie Inc. ABBV | 3 | $70.84 |
| Exact Sciences Corporation EXAS | 3 | $68.86 |
| Pfizer Inc. PFE | 2 | $35.68 |
| Novo Nordisk Inc NVO | 2 | $34.41 |
| Lilly USA, LLC LLY | 1 | $24.95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $22.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.